Type of amino acids | Intervention/treatment (design) | Type of cancer | NCT number | Phase | Status | Purpose |
---|---|---|---|---|---|---|
Glutamine | Dietary supplement of glutamine | Metastatic cancer | NCT04710290 | III | Enrolling | Evaluate the efficacy of glutamine supplementation in patients with metastatic cancers undergoing chemotherapy |
Dietary supplement of glutamine | Head and neck cancer | NCT00006994 | III | Terminated | Evaluate the efficacy and safety of L-Glutamine upon radiation therapy-induced oral mucositis in head and neck cancer patients | |
Dietary supplement of standard-glutamine Dietary supplement of standard-glutamine-omega 3 | Colorectal cancer | NCT01831310 | IV | Completed | Evaluate the effect of postoperative glutamine-dipeptide supplemented parenteral nutrition on neutrophil functions and postoperative course of patients with colorectal cancer | |
Drug: Glutamine | Colorectal Neoplasms | NCT01087658 | III | Completed | Evaluate the efficacy of oral glutamine in the prevention of oxaliplatin-induced neurotoxicity in patients with colorectal cancer treated with oxaliplatin | |
Drug: Glutamine | Kidney cancer | NCT00365768 | II | Completed | Study the effects of glutamine in pediatric patients with cancer | |
Dietary supplement of glutamine | Unspecified adult solid tumor | NCT00217724 | Not Applicable | Terminated | Study how effect glutamine in preventing myalgia and/or arthralgia in patients who are receiving paclitaxel for cancer | |
Drug: Glutamine | Advanced cancers | NCT01952847 | III | Terminated | Study glutamine function in reliving sores, blisters, or inflammation in the mouth or esophagus | |
Arginine | Dietary supplement of arginine | Head and neck cancer | NCT00559156 | II | Completed | Evaluate the impact of arginine for postoperative radio chemotherapy in patients with carcinoma of the head and neck |
Drug: oral L-arginine | Prostate cancer | NCT01105130 | II | Completed | Study effect of L-arginine supplementation in treating erectile dysfunction and quality of life of prostate cancer survivors previously treated with radiation therapy |